Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2022-11-16 00:00:00 ET · period of report 2022-11-14 · accession 0001883850-22-000096 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-11-16 | 2022-11-15 | REGN | MURPHY ANDREW J | EVP Research | S - Sale+OE | $727.81 | -3,720 | 60.4K | -6% | -$2.71M |
| D | 2022-11-16 | 2022-11-14 | REGN | MURPHY ANDREW J | EVP Research | G - Gift | $0.00 | -1,360 | 57.1K | -2% | $0 |
| D | 2022-11-16 | 2022-11-14 | REGN | MURPHY ANDREW J | EVP Research | M - OptEx | $179.13 | +10.0K | 67.1K | +18% | +$1.79M |
| D | 2022-11-16 | 2022-11-14 | REGN | MURPHY ANDREW J | EVP Research | F - Tax | $746.00 | -6,280 | 60.8K | -9% | -$4.68M |
| D | 2022-11-16 | 2022-11-14 | REGN | MURPHY ANDREW J | EVP Research | M - OptEx | $0.00 | -10.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-15 | S | D | 333 | $727.17 | 59,201 | D | — | — | (F8) Represents volume-weighted average price of sales of 333 shares of Company stock on November 15, 2022 at prices ranging from $727.02 to $727.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 15, 2022 at each separate price. |
| 2 | Common | Common Stock | 2022-11-15 | S | D | 361 | $728.44 | 58,840 | D | — | — | (F9) Represents volume-weighted average price of sales of 361 shares of Company stock on November 15, 2022 at prices ranging from $728.01 to $728.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 15, 2022 at each separate price. |
| 3 | Common | Common Stock | 2022-11-15 | S | D | 109 | $718.60 | 60,721 | D | — | — | (F2) Represents volume-weighted average price of sales of 109 shares of Company stock on November 15, 2022 at prices ranging from $718.44 to $718.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 15, 2022 at each separate price. |
| 4 | Common | Common Stock | 2022-11-15 | S | D | 336 | $719.62 | 60,385 | D | — | — | (F3) Represents volume-weighted average price of sales of 336 shares of Company stock on November 15, 2022 at prices ranging from $719.24 to $719.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 15, 2022 at each separate price. |
| 5 | Common | Common Stock | 2022-11-15 | S | D | 521 | $729.37 | 58,319 | D | — | — | (F10) Represents volume-weighted average price of sales of 521 shares of Company stock on November 15, 2022 at prices ranging from $729.01 to $729.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 15, 2022 at each separate price. |
| 6 | Common | Common Stock | 2022-11-15 | S | D | 315 | $730.57 | 58,004 | D | — | — | (F11) Represents volume-weighted average price of sales of 315 shares of Company stock on November 15, 2022 at prices ranging from $730.01 to $730.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 15, 2022 at each separate price. |
| 7 | Common | Common Stock | 2022-11-15 | S | D | 532 | $731.49 | 57,472 | D | — | — | (F12) Represents volume-weighted average price of sales of 532 shares of Company stock on November 15, 2022 at prices ranging from $731.03 to $731.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 15, 2022 at each separate price. |
| 8 | Common | Common Stock | 2022-11-15 | S | D | 78 | $732.40 | 57,394 | D | — | — | |
| 9 | Common | Common Stock | 2022-11-15 | S | D | 21 | $733.42 | 57,373 | D | — | — | (F13) Represents volume-weighted average price of sales of 21 shares of Company stock on November 15, 2022 at prices ranging from $733.41 to $733.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 15, 2022 at each separate price. |
| 10 | Common | Common Stock | 2022-11-15 | S | D | 64 | $734.59 | 57,309 | D | — | — | |
| 11 | Common | Common Stock | 2022-11-15 | S | D | 2 | $736.40 | 57,307 | D | — | — | |
| 12 | Common | Common Stock | 2022-11-15 | S | D | 66 | $741.61 | 57,241 | D | — | — | (F14) Represents volume-weighted average price of sales of 66 shares of Company stock on November 15, 2022 at prices ranging from $741.61 to $741.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 15, 2022 at each separate price. |
| 13 | Common | Common Stock | 2022-11-15 | S | D | 21 | $742.25 | 57,220 | D | — | — | |
| 14 | Common | Common Stock | 2022-11-15 | S | D | 100 | $744.01 | 57,120 | D | — | — | |
| 15 | Common | Common Stock | 2022-11-15 | S | D | 10 | $749.92 | 57,110 | D | — | — | |
| 16 | Common | Common Stock | 2022-11-14 | G | D | 1,360 | $0.00 | 57,110 | D | — | — | |
| 17 | Common | Common Stock | 2022-11-14 | M | A | 10,000 | $179.13 | 67,110 | D | — | — | |
| 18 | Common | Common Stock | 2022-11-14 | F | D | 6,280 | $746.00 | 60,830 | D | — | — | |
| 19 | Common | Common Stock | 2022-11-15 | S | D | 222 | $726.48 | 59,534 | D | — | — | (F7) Represents volume-weighted average price of sales of 222 shares of Company stock on November 15, 2022 at prices ranging from $726.00 to $726.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 15, 2022 at each separate price. |
| 20 | Common | Common Stock | 2022-11-15 | S | D | 57 | $723.19 | 59,756 | D | — | — | (F6) Represents volume-weighted average price of sales of 57 shares of Company stock on November 15, 2022 at prices ranging from $723.13 to $723.45. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 15, 2022 at each separate price. |
| 21 | Common | Common Stock | 2022-11-15 | S | D | 272 | $722.36 | 59,813 | D | — | — | (F5) Represents volume-weighted average price of sales of 272 shares of Company stock on November 15, 2022 at prices ranging from $722.26 to $722.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 15, 2022 at each separate price. |
| 22 | Common | Common Stock | 2022-11-15 | S | D | 297 | $721.74 | 60,085 | D | — | — | (F4) Represents volume-weighted average price of sales of 297 shares of Company stock on November 15, 2022 at prices ranging from $721.05 to $721.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 15, 2022 at each separate price. |
| 23 | Common | Common Stock | 2022-11-15 | S | D | 3 | $720.26 | 60,382 | D | — | — | |
| 24 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-11-14 | M | D | 10,000 | $0.00 | 0 | D | $179.13 · — to 2022-12-14 | 10,000 Common Stock | (F15) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |